The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD

被引：2
|
作者：
Dobler, Claudia C. [1 ]
机构：
[1] Mayo Clin, Evidence Based Practice Ctr, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA
来源：
BREATHE | 2018年 / 14卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1183/20734735.026418
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：333 / 335
页数：3
相关论文
共 50 条
  • [41] EFFECT OF ONCE-DAILY SINGLE-INHALER FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL TRIPLE THERAPY ON EXACERBATIONS COMPARED WITH BUDESONIDE/FORMOTEROL DUAL THERAPY IN PATIENTS WITH COPD AND NO HISTORY OF EXACERBATIONS: A POST HOC ANALYSIS OF THE FULFIL STUDY
    Panettieri, Reynold
    Bangalore, Mohan
    Camargo, Carlos
    Cheema, Tariq
    El Bayadi, Sherif
    Fiel, Stanley
    Jain, Renu
    Midwinter, Dawn
    Rabadi, Nashat
    Thomashow, Byron
    Lipson, David
    CHEST, 2021, 160 (04) : 1822A - 1825A
  • [42] Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety
    Suissa, Samy
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (03)
  • [43] Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice
    Lassan, S.
    Keszegh, J.
    Lassanova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (01): : 27 - 36
  • [44] COST-EFFECTIVENESS ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYA') VS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE
    Balmaceda, C.
    Abbott, T.
    Espinoza, M. A.
    VALUE IN HEALTH, 2020, 23 : S354 - S354
  • [45] Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review
    Rana, Rezwanul Hasan
    Alam, Khorshed
    Keramat, Syed Afroz
    Gow, Jeff
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (10) : 1067 - 1084
  • [46] ECONOMIC ANALYSIS OF NEW SINGLE-INHALER TRIPLE THERAPIES IN PATIENTS WITH COPD IN THE UK
    Cai, R.
    Martin, A.
    Ge, Y.
    Risebrough, N.
    Sharma, R.
    Haeussler, K.
    Compton, C.
    Halpin, D.
    Ismaila, A. S.
    VALUE IN HEALTH, 2022, 25 (12) : S183 - S184
  • [47] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2021, 26 : 119 - 119
  • [48] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, A.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2020, 25 : 145 - 145
  • [49] Therapeutic Response to Single-Inhaler Triple Therapies in Moderate-to-Severe COPD
    Ohtsuka, Kengo
    Harada, Naoko
    Horiuchi, Atsuo
    Umemoto, Shintaro
    Kurabatashi, Ryo
    Yui, Akie
    Yamamura, Hiroyuki
    Shinka, Yoko
    Miyao, Naoki
    RESPIRATORY CARE, 2023, 68 (03) : 330 - 337
  • [50] THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Vallejo-Aparicio, L. A.
    Paly, V. F.
    Schroeder, M.
    Martin, A.
    Risebrough, N.
    Abreu, C.
    Biswas, C.
    Izquierdo Alonso, J. L.
    Riesco Miranda, J. A.
    Soler Cataluna, J. J.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S878 - S878
12345